Chase for Ten-Baggers Keeps After Cancer (MIPI, ENMD)
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) is surging this morning on solid news in the war on cancer. Any time you have a gain of 100% or more in a single day, the term “surge” is an...
View ArticleMolecular Insight Shoots Up Overnight On Promising Cancer Trials
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) was up $0.66 (41.25%) to $2.26 this morning on news that mid-stage trials of their cancer drug, Azedra, were going exceptionally well. Azedra...
View Article
More Pages to Explore .....
